Jonathan I. Lieber - 07 Jun 2022 Form 4 Insider Report for Salarius Pharmaceuticals, Inc. (SLRX)

Role
Director
Signature
/s/Mark Rosenblum, as Attorney-in-Fact
Issuer symbol
SLRX
Transactions as of
07 Jun 2022
Net transactions value
+$7,016
Form type
4
Filing time
08 Jun 2022, 15:12:16 UTC
Previous filing
21 Jan 2022
Next filing
24 Aug 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLRX Common Stock Purchase $7,016 +37,500 $0.1871 37,500 07 Jun 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.